CD22 Chimeric Monoclonal Antibody

CD22 Chimeric Monoclonal Antibody by Molecular Depot is a chimeric monoclonal antibody that recognises human CD22, a sialic acid-binding lectin of the Siglec family on B cells. CD22 acts as an inhibitory coreceptor of the B cell receptor. It is used to detect and target CD22-positive B cells in lymphoma, leukaemia and B cell signalling research. Each unit contains 100 µg. MBP supplies Molecular Depot antibodies to research labs in the United States, Canada and worldwide.